The Haematology and Bone Marrow Transplantation Unit at Westmead Hospital offers haematology clinical research trials to patients in Western Sydney suffering from haematological blood disorders and malignancies.
Westmead Haematology and Bone Marrow Transplantation Unit manages a large portfolio of trials exploring better treatment options for patients with leukaemia, lymphoma, myeloma and associated stem cell transplants. The Unit participates in a significant number of early phase trials in addition to phase II and III trials, and maintains a balance of trials sponsored by Pharmaceutical companies and not-for-profit organisations, through a strong association with the collaborative clinical research group Australasian Leukaemia & Lymphoma Group (ALLG). The Unit also conducts investigator initiated studies, particularly in the area of non-malignant haematology such as venous thrombosis, bleeding disorders and obstetric haematology.
We have an extensive Cell Therapies program including clinical trials, basic and translational research involving CAR T-cells and viral-specific T cells, developing and administering therapies to improve cure rates from haematological malignancy and improve quality of life and survival post- transplant by improved immune reconstitution. This program facilitates access for Australian patients to new therapeutic options.
The unit benefits from a close relationship between a large team of experienced haematology clinicians, nurses and clinical trial coordinators, ensuring that as many patients as possible are offered the opportunity to participate in a high quality clinical trial which may present additional treatment options for patients now or in the future.
Westmead Haematology and Bone Marrow Transplantation Unit can be contacted on Telephone (02) 8890 7219.
Looking for General